Idi na sadržaj

Urologija

Kontroliranje i optimizacija hemostaze

Antifibrinolitička sredstva

Tranexamic acid in patients undergoing noncardiac surgery. (otvara se novi prozor)

Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, Chan MTV, Borges FK, Martínez-Zapata MJ, Wang CY, Xavier D, Ofori SN, Wang MK, Efremov S, Landoni G, Kleinlugtenbelt YV, Szczeklik W, Schmartz D, Garg AX, Short TG, Wittmann M, Meyhoff CS, Amir M, Torres D, Patel A, Duceppe E, Ruetzler K, Parlow JL, Tandon V, Fleischmann E, Polanczyk CA, Lamy A, Astrakov SV, Rao M, Wu WKK, Bhatt K, de Nadal M, Likhvantsev VV, Paniagua P, Aguado HJ, Whitlock RP, McGillion MH, Prystajecky M, Vincent J, Eikelboom J, Copland I, Balasubramanian K, Turan A, Bangdiwala SI, Stillo D, Gross PL, Cafaro T, Alfonsi P, Roshanov PS, Belley-Côté EP, Spence J, Richards T, VanHelder T, McIntyre W, Guyatt G, Yusuf S, Leslie K; POISE-3 Investigators

Izvor‎: N Engl J Med. 2022;386(21):1986-97.

Indeks‎: PubMed 35363452

DOI‎: 10.1056/NEJMoa2201171

https://pubmed.ncbi.nlm.nih.gov/35363452/ (otvara se novi prozor)

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (otvara se novi prozor)

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K.

Izvor‎: Cochrane Database Syst Rev 2011;(3):CD001886.

Indeks‎: PubMed 21412876

DOI‎: 10.1002/14651858.CD001886.pub4

https://www.ncbi.nlm.nih.gov/pubmed/21412876 (otvara se novi prozor)

Tranexamic acid reduces blood loss during percutaneous nephrolithotomy: a prospective randomized controlled study. (otvara se novi prozor)

Kumar S, Randhawa MS, Ganesamoni R, Singh SK.

Izvor‎: J Urol 2013;189(5):1757-61.

Indeks‎: PubMed 23123376

DOI‎: 10.1016/j.juro.2012.10.115

https://www.ncbi.nlm.nih.gov/pubmed/23123376 (otvara se novi prozor)

Rekombinirani aktivirani faktor VII (rFVIIa)